These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17875955)

  • 21. Concentrations of hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor in pericardial fluid and plasma.
    Kubota T; Namiki A; Fukazawa M; Ishikawa M; Moroi M; Ebine K; Yamaguchi T
    Jpn Heart J; 2004 Nov; 45(6):989-98. PubMed ID: 15655274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarction.
    Guo H; Huang L; Cheng M; Jin X; Zhao Y; Yi M
    Neurosci Lett; 2006 Jan; 393(1):56-9. PubMed ID: 16229951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
    Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
    Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
    Ohno T; Yuge T; Kariyazono H; Igarashi H; Joh-o K; Kinugawa N; Kusuhara K; Hara T
    Eur J Pediatr; 2002 Feb; 161(2):105-11. PubMed ID: 11954744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease.
    Tateishi J; Waku S; Masutani M; Ohyanagi M; Iwasaki T
    Am Heart J; 2002 Feb; 143(2):272-6. PubMed ID: 11835030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravascular ultrasound evidence of angiographically silent allograft vasculopathy inversely correlates with circulating level of hepatocyte growth factor.
    Lee CM; Wu YW; Chou NK; Jui HY; Hsu RB; Wang SS; Chen MF
    J Heart Lung Transplant; 2006 Dec; 25(12):1456-61. PubMed ID: 17178341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
    Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.
    Okada M; Matsumori A; Ono K; Miyamoto T; Takahashi M; Sasayama S
    Biochem Biophys Res Commun; 1999 Feb; 255(1):80-7. PubMed ID: 10082659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery--a pilot study.
    Wildgruber M; Weiss W; Berger H; Eckstein HH; Wolf O; Heider P
    Br J Radiol; 2007 Jun; 80(954):430-6. PubMed ID: 17202198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte mean corpuscular volume associated with the anatomical distribution in peripheral arterial disease.
    Mueller T; Luft C; Haidinger D; Poelz W; Haltmayer M
    Vasa; 2002 May; 31(2):81-5. PubMed ID: 12099149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased urinary albumin excretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease.
    Sonmez K; Eskisar AO; Demir D; Yazicioglu MV; Mutlu B; Dogan Y; Izgi A; Mansuroglu D; Bakal RB; Elonu OH; Turan F
    Angiology; 2006; 57(1):15-20. PubMed ID: 16444452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and immunomorphological evaluation of hepatocyte growth factor and c-Met pathway in patients with critical limb ischemia.
    Vasuri F; Fittipaldi S; Abualhin M; Degiovanni A; Gargiulo M; Stella A; Pasquinelli G
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):430-7. PubMed ID: 24947080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term prognostic value of subclinical carotid and femoral arterial wall lesions in patients with ST-elevation-myocardial infarction having percutaneous coronary intervention.
    Monopoli DE; Bertelli L; Sgura FA; Politi L; Becirovic M; Iaccarino D; Lattanzi A; Rampino K; Gorlato G; Menozzi M; Zennaro RG; Rossi R
    Am J Cardiol; 2013 Mar; 111(5):649-56. PubMed ID: 23246270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum basic fibroblast growth factor levels in patients with ischemic heart disease.
    Hasdai D; Barak V; Leibovitz E; Herz I; Sclarovsky S; Eldar M; Scheinowitz M
    Int J Cardiol; 1997 Apr; 59(2):133-8. PubMed ID: 9158164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrovascular disease and intracranial artery stenosis in patients with symptomatic peripheral artery disease.
    Aizawa H; Azuma N; Katayama T; Hasebe N; Inaba M; Sasajima T; Uchiyama S
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):825-31. PubMed ID: 21703877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of coronary artery disease and left ventricular dysfunction on postoperative mortality in vascular surgery.
    Nagaoka H; Innami R; Funakoshi N; Fujiwara A; Watanabe M
    J Cardiovasc Surg (Torino); 1992; 33(5):521-5. PubMed ID: 1447267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.